Product Information

OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $0.6443 per EA under NDC 47781046813. Its NADAC has been published 508 times since Feb 22, 2017.

FDA first approved this application on Aug 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR PHOS 30 MG CAPSULE

Oseltamivir phosphate
$0.6443per EA

Strength

30 mg/1

Manufacturer

Alvogen Inc.

NDC

47781046813

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202595

FDA Approved

8/3/2016

TE Code

AB

On Market Since

12/12/2016

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 508 times since Feb 22, 2017, and over the history we have for it it has declined 92.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6443 per EA
All-time high$8.7338 (May 10, 2017)
All-time low$0.6013 (Aug 20, 2025)
52-week high$0.8323
52-week low$0.6443
Median price$2.2425
Average price$3.2801
Largest weekly change+62.9% (Jan 25, 2023)
Weeks tracked508
Tracking sinceFeb 22, 2017

Price History

1W

0.0%

1M

-5.2%

3M

-5.3%

6M

-14.7%

1Y

-4.4%

3Y

-46.1%

5Y

-71.3%

All

-92.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Alvogen Inc., is $0.6443 per EA (NDC 47781046813), effective Nov 11, 2026.

How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 92.6%. It has been tracked across 508 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?

Since Feb 22, 2017, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.7338 (May 10, 2017), with a median of $2.2425 per EA.

Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?

OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 47781046813) is labeled by Alvogen Inc., and CMS classifies it as a generic product.